Dermata Therapeutics, Inc. (DRMA)
1.19
-0.05
(-4.03%)
USD |
NASDAQ |
Mar 13, 16:00
1.195
0.00 (0.00%)
Pre-Market: 20:00
Dermata Therapeutics EPS Diluted (Quarterly) : -1.648 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ekso Bionics Holdings, Inc. | -1.568 |
| Citius Pharmaceuticals, Inc. | -0.3824 |
| Aptevo Therapeutics, Inc. | -40.13 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.692M |
| Total Expenses (Quarterly) | 1.692M |
| Enterprise Value | -1.290M |
| Earnings Yield | -1.37K% |
| Normalized Earnings Yield | -1366.99 |